ALK and anaplastic large cell lymphoma: In the hematopoietic system, C/EBPβ is a pro-oncogenic factor in ALK-positive anaplastic large cell lymphoma (ALCL) [64,65] as a crucial downstream target of oncogenic ALK-signalling.